Given the pivotal roles of STK4 and IRAK1 in the production of proinflammatory cytokines and cell proliferation in liver tumor cells, targeting STK4 and IRAK1 may present a novel strategy for inhibiting the development of inflammation-related liver cancer. The gene discussed is STK4; the disease is liver cancer.